Ab Index-Nr. 613-095-00-4

Index-Nr.Internationale chemische BezeichnungEG-Nr.CAS-Nr.EinstufungKennzeichnungbis 30.11.2018: Spezifische Konzentrations-
grenzen,
M-Faktoren
ab 01.12.2018: Spezifische Konzentrations-
grenzen
M-Faktoren und ATE
Anmer-
kungen
Gefahrenklasse, Gefahren-
kategorie und Gefahren-
kodierung
Kodierung der Gefahrenhin-
weise
Piktogramm, Kodierung der SignalworteKodierung der Gefahrenhin-
weise
Kodierung der ergänzenden Gefahren-
merkmale
613-095-00-4sodium 3-(2H-benzotriazol-
2-yl)-5-sec-butyl-4-hydroxy-
benzenesulfonate
403-080-992484-48-5Eye Dam. 1H318GHS05
Dgr
H318   
613-096-00-X2-amino-6-ethoxy-4-methyl-
amino-1,3,5-triazine
403-580-762096-63-3Acute Tox. 4 (*)H302GHS07
Wng
H302   
613-097-00-57-amino-3-((5-carboxymethyl-
4-methyl-1,3-thiazol-2-
ylthio)methyl)-8-oxo-5-thia-
1-azabicyclo(4.2.0)oct-2-ene-
2-carboxylic acid
403-690-5111298-82-9Resp. Sens. 1
Skin Sens. 1
Aquatic Chronic 3
H334
H317
H412
GHS08
Dgr
H334
H317
H412
   
613-098-00-0N-(n-octyl)-2-pyrrolidone403-700-82687-94-7Skin Corr. 1B
Aquatic Chronic 2
H314
H411
GHS05
GHS09
Dgr
H314
H411
   
613-099-00-61-dodecyl-2-pyrrolidone403-730-12687-96-9Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H314
H317
H400
H410
GHS05
GHS07
GHS09
Dgr
H314
H317
H410
   
613-100-00-X2,9-bis(3-(diethylamino)propylsulfamoyl)
quino(2,3-b)acridine-7,14-dione
404-230-6Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413
   
613-101-00-5N–tert-pentyl-2-benzothiazolesulfenamide404-380-2110799-28-5Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412
   
613-102-00-0dimethomorph (ISO);
4-(3-(4-chlorophenyl)-3-(3,4-dimethoxyphe-
nyl)acryloyl)morpholine
404-200-2110488-70-5Aquatic Chronic 2H411GHS09H411   
613-103-00-6sodium 5-n-butylbenzotriazole404-450-2118685-34-0Acute Tox. 4 (*)
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 2
H302
H314
H317
H411
GHS05
GHS07
GHS09
Dgr
H302
H314
H317
H411
   
613-104-00-15-tert-butyl-3-isoxazolylamine hydrochloride404-840-2Acute Tox. 4 (*)
STOT RE 2 (*)
Eye Dam. 1
Aquatic Chronic 3
H302
H373 (*)(*)
H318
H412
GHS08
GHS05
GHS07
Dgr
H302
H373 (*)(*)
H318
H412
   
613-105-00-7hexakis(tetramethylam-
monium) 4,4'-vinylene-
bis((3-sulfonato-4,1-phenyle-
ne)imino(6-morpholino-1,3,5-
triazine-4,2-diyl)imino)bis(5-
hydroxy-6-phenylazonaph-
thalene-2,7-disulfonate)
405-160-9124537-30-0Acute Tox. 3 (*)
Skin Sens. 1
Aquatic Chronic 3
H301
H317
H412
GHS06
Dgr
H301
H317
H412
   
613-106-00-2tetrapotassium
2-(4-(5-(1-(2,5-disulfonato-
phenyl)-3-ethoxycarbonyl-5-
hydroxypyrazol-4-yl)penta-
2,4-dienylidene)-3-ethoxycar-
bonyl-5-oxo-2-pyrazolin-1-
yl)benzene-1,4-disulfonate
405-240-3Skin Sens. 1H317GHS07
Wng
H317   
613-107-00-8hexasodium
2,2'-vinylenebis((3-sulfonato-
4,1-phenylene)imino(6-(N-
cyanoethyl-N-(2-hydroxy-
propyl)amino)-1,3,5-triazine-
4,2-diyl)imino)dibenzene-
1,4-disulfonate
405-280-176508-02-6Eye Irrit. 2H319GHS07
Wng
H319   
613-108-00-3benzothiazole-2-thiol205-736-8149-30-4Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410
   
613-109-00-9bis(piperidinothiocarbonyl) disulphide202-328-194-37-1Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
H319
H335
H315
H317
GHS07
Wng
H319
H335
H315
H317
   
613-110-00-4dimepiperate (ISO);
S-(1-methyl-1-phenylethyl) piperidine-1-carbothioate
262-784-261432-55-1Acute Tox. 4 (*)
Aquatic Chronic 2
H302
H411
GHS07
GHS09
Wng
H302
H411
   
613-111-00-X1,2,4-triazole206-022-9288-88-0Repr. 2
Acute Tox. 4 (*)
Eye Irrit. 2
H361d
(*)(*)(*)
H302
H319
GHS08
GHS07
Wng
H361d
(*)(*)(*)
H302
H319
   
613-112-00-5octhilinone (ISO);
2-octyl-2H-isothiazol-3-one
247-761-726530-20-1Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 4 (*)
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H331
H311
H302
H314
H317
H400
H410
GHS06
GHS05
GHS09
Dgr
H331
H311
H302
H314
H317
H410
 Skin Sens. 1;
H317: C ≥ 0,05 %
 
613-113-00-02-(morpholinothio)benzo-
thiazole
203-052-4102-77-2Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
H319
H315
H317
H411
GHS07
GHS09
Wng
H319
H315
H317
H411
   
613-114-00-62,2',2"-(hexahydro-1,3,5-
triazine-1,3,5-triyl)
triethanol;
1,3,5-tris(2-hydroxyethyl)he-
xahydro-1,3,5-triazine
225-208-04719-04-4Acute Tox. 4 (*)
Skin Sens. 1
H302
H317
GHS07
Wng
H302
H317
 Skin Sens. 1;
H317: C ≥ 0,1 %
 
613-115-00-1hymexazol (ISO);
3-hydroxy-5-methylisoxazole
233-000-610004-44-1Acute Tox. 4 (*)
Eye Dam. 1
Aquatic Chronic 3
H302
H318
H412
GHS05
GHS07
Dgr
H302
H318
H412
   
613-116-00-7tolylfluanid (ISO);
dichloro-N-[(dimethylami-
no)sulphonyl]fluoro-
N-(p-tolyl)methanesulphen-
amide;
[containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]
211-986-9731-27-1Acute Tox. 2*
STOT RE 1
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
H330
H372 **
H319
H335
H315
H317
H400
GHS06
GHS08
GHS09
Dgr
H330
H372 **
H319
H335
H315
H317
H400
 M = 10 
613-116-01-4tolylfluanid (ISO);
dichloro-N-[(dimethylami-
no)sulphonyl]fluoro-N-(p-
tolyl)methanesulphenamide;
[containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]
211-986-9731-27-1Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
H319
H335
H315
H317
H400
GHS07
GHS09
Wng
H319
H335
H315
H317
H400
 M = 10 
613-117-00-2diniconazole (ISO);
(E)-β-[(2,4-dichloro-
phenyl)methylene]-α-
(1,1-dimethylethyl)-1H-1,2,4-
triazol-1-ethanol;
(E)-(RS)-1-(2,4-dichloro-
phenyl)-4,4-dimethyl-2-(1H-
1,2,4-triazol-1-yl)pent-1-en-3-ol
76714-88-0Acute Tox. 4 (*)
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410
   
613-118-00-8flubenzimine (ISO);
N-[3-phenyl-4,5-bis[(trifluoro-
methyl)imino]thiazolidin-2-
ylidene]aniline
253-703-137893-02-0Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H319
H400
H410
GHS07
GHS09
Wng
H319
H410
   
613-119-00-3(benzothiazol-2-ylthio)methyl thiocyanate;
TCMTB
244-445-021564-17-0Acute Tox. 2 (*)
Acute Tox. 4 (*)
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H330
H302
H319
H315
H317
H400
H410
GHS06
GHS09
Dgr
H330
H302
H319
H315
H317
H410
   
613-120-00-9bioresmethrin (ISO);
(5-benzyl-3-furyl)methyl (1R)-
2,2-dimethyl-3-(2-methylprop-
1-en-1-yl)cyclopropane-
carboxylate
249-014-028434-01-7Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410 M = 1000 
bis 28.02.2018
613-121-00-4
chlorsulfuron (ISO);
2-chloro-N-[[(4-methoxy-6-
methyl-1,3,5-triazin-2-
yl)amino]carbonyl]benzene-
sulphonamide
265-268-564902-72-3Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410   
ab 01.03.2018*):
*) Die harmonisierten Einstufungen dürfen bereits vor dem genannten Datum verwendet werden.
613-121-00-4
Chlorsulfuron (ISO);
2- Chlor-N-[[(4-methoxy-
6-methyl-1,3,5-triazin-
2- yl)amino]carbonyl]
benzolsulfonamid
265-268-564902-72-3Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410 M = 1000
M = 100
 
613-122-00-Xdiclobutrazole (ISO);
(R(*), R(*))-(±)-β-
[(2,4-dichlorophenyl)me-
thyl]-α-(1,1-dimethyl-
ethyl)-1H-1,2,4-triazole-1-
ethanol;
(2RS, 3RS)-1-(2,4-dichloro-
phenyl)-4,4-dimethyl-2-(1H-
1,2,4-triazol-1yl)pentan-3-ol
75736-33-3Eye Irrit. 2
Aquatic Chronic 2
H319
H411
GHS07
GHS09
Wng
H319
H411
   
613-123-00-55,6-dihydro-3H-imidazo[2,1-
c]-1,2,4-dithiazole-3-thione;
etem
251-684-433813-20-6Acute Tox. 4 (*)
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410
   
613-124-00-0fenpropimorph (ISO);
cis-4-[3-(p–tert-butyl-
phenyl)-2-methylpropyl]-
2,6-dimethylmorpholine
266-719-967564-91-4Repr. 2
Acute Tox. 4 (*)
Skin Irrit. 2
Aquatic Chronic 2
H361d
(*)(*)(*)
H302
H315
H411
GHS08
GHS07
GHS09
Wng
H361d
(*)(*)(*)
H302
H315
H411
   
613-125-00-6hexythiazox(ISO);
trans-5-(4-chlorophenyl)-N-
cyclohexyl-4-methyl-2-oxo-3-
thiazolidine-carboxamide
78587-05-0Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410   
613-126-00-1imazapyr (ISO);
2-[4,5-dihydro-4-methyl-4-(1-
methylethyl)-5-oxo-1H-
imidazol-2-yl]-3-pyridine carboxylate
81334-34-1Eye Irrit. 2
Aquatic Chronic 3
H319
H412
GHS07
Wng
H319
H412
   
613-127-00-71,1-dimethylpiperidinium chloride;
mepiquat chloride
246-147-624307-26-4Acute Tox. 4 (*)
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412
   
613-128-00-2prochloraz (ISO);
N-propyl-N-[2-(2,4,6-trichloro-
phenoxy)ethyl]-1H-imidazole-
1-carboxamide
266-994-567747-09-5Acute Tox. 4 (*)
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410
   
613-129-00-8metamitron (ISO);
4-amino-3-methyl-6-phenyl-
1,2,4-triazin-5-one
255-349-341394-05-2Acute Tox. 4 (*)
Aquatic Acute 1
H302
H400
GHS07
GHS09
Wng
H302
H400
   
613-131-00-9pyroquilon (ISO);
1,2,5,6-tetrahydropyrro-
lo[3,2,1-ij]quinolin-4-one
57369-32-1Acute Tox. 4 (*)
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412
   
613-132-00-4hexazinone (ISO);
3-cyclohexyl-6-dimethylami-
no-1-methyl-1,2,3,4-tetra-
hydro-1,3,5-triazine-2,4-dione
257-074-451235-04-2Acute Tox. 4 (*)
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H302
H319
H400
H410
GHS07
GHS09
Wng
H302
H319
H410
   
613-133-00-XEtridiazol (ISO);
5-Ethoxy-3-trichlormethyl-
1,2,4-thiadiazol
219-991-82593-15-9Carc. 2
Acute Tox. 4
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H351
H302
H317
H400
H410
GHS08
GHS07
GHS09
Wng
H351
H302
H317
H410
 M = 1
M = 1
 
613-134-00-5myclobutanil(ISO);
2-(4-chlorophenyl)-2-(1H-
1,2,4-triazol-1-ylmethyl)he-
xanenitrile
88671-89-0Repr. 2
Acute Tox. 4 (*)
Eye Irrit. 2
Aquatic Chronic 2
H361d
(*)(*)(*)
H302
H319
H411
GHS08
GHS07
GHS09
Wng
H361d
(*)(*)(*)
H302
H319
H411
   
613-135-00-0di(benzothiazol-2-yl) disulphide204-424-9120-78-5Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410
EUH031  
613-136-00-6N-cyclohexylbenzothiazole-
2-sulphenamide
202-411-295-33-0Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410
   
613-137-00-1methabenzthiazuron (ISO);
1-(1,3-benzothiazol-2-yl)1,3-
dimethylurea
242-505-018691-97-9Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410   
613-138-00-7quinoxyfen (ISO);
5,7-dichloro-4-(4-fluorophenoxy)quinoline
124495-18-7Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410
   
613-139-00-2metsulfuron-methyl (ISO);
methyl 2-{[(4-methoxy-6-
methyl-1,3,5- triazin-2-yl)car-
bamoyl]sulfamoyl}benzoate
74223-64-6Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410 M = 1000 
613-140-00-8cycloheximide (ISO);
4-{(2R)-2-[(1S,3S,5S)-3,5-
dimethyl-2-oxocyclohexyl]-
2-hydroxyethyl}piperidine-
2,6-dione
200-636-066-81-9Muta. 2
Repr. 1B
Acute Tox. 2 (*)
Aquatic Chronic 2
H341
H360D
(*)(*)(*)
H300
H411
GHS06
GHS08
GHS09
Dgr
H341
H360D
(*)(*)(*)
H300
H411
   
613-141-00-31,4-diamino-2-(2-butyltetrazol-
5-yl)-3-cyanoanthraquinone
401-470-393686-63-6Aquatic Chronic 4H413H413   
613-142-00-9trans–N-methyl-2-styryl-
[4'-aminomethine-(1-acetyl-
1-(2-methoxyphenyl)aceta-
mido)]pyridinium acetate
405-860-4Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
   
613-143-00-41-(3-phenylpropyl)-2-methyl-
pyridinium bromide
405-930-410551-42-5Acute Tox. 4 (*)
Eye Irrit. 2
Aquatic Chronic 3
H302
H319
H412
GHS07
Wng
H302
H319
H412
   
613-144-00-Xreaction products of:
poly(vinyl acetate),
partially hydrolyzed, with (E)-2-(4-formylstyryl)-3,4-
dimethylthiazoliummethyl sulfate
406-460-2125139-08-4Aquatic Chronic 3H412H412   
613-145-00-5(S)-3-benzyloxycarbonyl-
1,2,3,4-tetrahydroisoquinoli-
nium 4-methylbenzenesulfonate
406-960-077497-97-3Aquatic Chronic 2H411GHS09H411   
613-146-00-0N-ethyl-N-methylpiperidinium iodide407-780-54186-71-4Acute Tox. 4 (*)
Aquatic Chronic 2
H302
H411
GHS07
GHS09
Wng
H302
H411
   
613-147-00-64-[2-(1-methyl-2-(4-morpho-
linyl)ethoxy)ethyl]morpholine
407-940-4111681-72-2Eye Dam. 1H318GHS05
Dgr
H318   
613-148-00-1tetrasodium
1,2-bis(4-fluoro-6-[5-(1-amino-
2-sulfonatoanthrachinon-4-
ylamino)-2,4,6-trimethyl-3-
sulfonatophenylamino]-1,3,5-
triazin-2-ylamino)ethane
411-240-4143683-23-2Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412
   
613-149-00-7Pyridaben (ISO);
2-tert-Butyl-5-(4-tert-butyl-
benzylthio)-4-chlorpyri-
dazin-3 (2H)-on
405-700-396489-71-3Acute Tox. 3
Acute Tox. 3
Aquatic Acute 1
Aquatic Chronic 1
H331
H301
H400
H410
GHS06
GHS09
Dgr
H331
H301
H410
 M = 1000
M = 1000
 
613-150-00-22,2'-[3,3'-(piperazine-1,4-
diyl)dipropyl]bis(1H-benzimi-
dazo[2,1-b]benzo[l,m,n][3,8]
phenanthroline-1,3,6-trione
406-295-6Aquatic Chronic 4H413H413   
613-151-00-81-(3-mesyloxy-5-trityloxy-
methyl-2-D-threofuryl)thymine
406-360-9104218-44-2Aquatic Chronic 4H413H413   
613-152-00-3phenyl N-(4,6-dimethoxy-
pyrimidin-2-yl)carbamate
406-600-289392-03-0Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
   
613-153-00-92,3,5-trichloropyridine407-270-216063-70-0Aquatic Chronic 3H412H412   
613-154-00-42-amino-4-chloro-6-
methoxypyrimidine
410-050-95734-64-5Acute Tox. 4 (*)H302GHS07
Wng
H302   
613-155-00-X5-chloro-2,3-difluoropyridine410-090-789402-43-7Flam. Liq. 3
Acute Tox. 4 (*)
Aquatic Chronic 3
H226
H302
H412
GHS02
GHS07
Wng
H226
H302
H412
   
613-156-00-52-butyl-4-chloro-5-
formylimidazole
410-260-083857-96-9Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
   
613-157-00-02,4-diamino-5-methoxy-
methylpyrimidine
410-330-054236-98-5Acute Tox. 4 (*)
STOT RE 2 (*)
Eye Irrit. 2
H302
H373 (*)(*)
H319
GHS08
GHS07
Wng
H302
H373 (*)(*)
H319
   
613-158-00-62,3-dichloro-5-trifluoromethyl-
pyridine
410-340-569045-84-7Acute Tox. 4 (*)
Acute Tox. 4 (*)
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2
H332
H302
H318
H317
H411
GHS05
GHS07
GHS09
Dgr
H332
H302
H318
H317
H411
   
613-159-00-1fenazaquin (ISO);
4-[2-[4-(1,1-dimethylethyl)phe-
nyl]-ethoxy]quinazoline
410-580-0120928-09-8Acute Tox. 3 (*)
Acute Tox. 4 (*)
Aquatic Acute 1
Aquatic Chronic 1
H301
H332
H400
H410
GHS06
GHS09
Dgr
H301
H332
H410
   
613-160-00-7(1S)-2-methyl-2,5-diazobi-
cyclo[2.2.1]heptane dihydrobromide
411-000-9125224-62-6Skin Sens. 1H317GHS07
Wng
H317   
613-161-00-2(2,4-diaminopteridin-6-yl)me-
thanol hydrobromide
430-620-076145-91-0STOT RE 2 *
Skin Sens. 1
Aquatic Chronic 3
H373 **
H317
H412
GHS08
GHS07
Wng
H373 **
H317
H412
   
613-162-00-8(6R-trans)-1-((7-ammonio-2-
carboxylato-8-oxo-5-thia-1-
azabicyclo-[4.2.0]oct-2-en-3-
yl)methyl)pyridinium iodide
423-260-0100988-63-4Muta. 2
Skin Sens. 1
Aquatic Chronic 2
H341
H317
H411
GHS08
GHS07
GHS09
Wng
H341
H317
H411
   
613-163-00-3azimsulfuron (ISO);
1-(4,6-dimethoxypyrimidin-
2-yl)-3-[1-methyl-4-(2-methyl-
2H-tetrazol-5-yl)pyrazol-5-
ylsulfonyl]urea
120162-55-2Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410 M = 1000 
613-164-00-9flufenacet (ISO);
N-(4-fluorophenyl)-N-isopropyl-
2-(5-trifluoromethyl-[1,3,4]thia-
diazol-2-yloxy)acetamide
142459-58-3Acute Tox. 4 *
STOT RE 2 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H373 **
H317
H400
H410
GHS08
GHS07
GHS09
Wng
H302
H373 **
H317
H410
 M = 100 
613-165-00-4flupyrsulfuron-methyl-sodium (ISO);
methyl 2-[[(4,6-dimethoxy-
pyrimidin-2-ylcarbamoyl)sul-
famoyl]-6-trifluoromethyl]ni-
cotinate, monosodium salt
144740-54-5Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410 M = 100 
bis 28.02.2018
613-166-00-X
flumioxazin (ISO);
N-(7-fluoro-3,4-dihydro-3-oxo-
4-prop-2-ynyl-2H-1,4-ben-
zoxazin-6-yl)cyclohex-1-ene-
1,2-dicarboxamide
103361-09-7Repr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H360D ***
H400
H410
GHS08
GHS09
Dgr
H360D ***
H410
 M = 1000 
ab 01.03.2018*):
*) Die harmonisierten Einstufungen dürfen bereits vor dem genannten Datum verwendet werden.
613-166-00-X
Flumioxazin (ISO);
2-[7-Fluor-3-oxo-4-
(prop-2-yn-1-yl)-3,4-di-
hydro-2H-1,4-benzox-
azin-6-yl]-4,5,6,7-tetra-
hydro-1H-isoindol-1,3
(2H)-dion
103361-09-7Repr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H360D
H400
H410
GHS08
GHS09
Dgr
H360D
H410
 M = 1000
M = 1000
 
613-167-00-5reaction mass of: 5-chloro-2-
methyl-4-isothiazolin-3-one [EC no. 247-500-7]
and 2-methyl-2H -isothiazol-
3-one [EC no. 220-239-6] (3:1);
reaction mass of: 5-chloro-
2-methyl-4-isothiazolin-3-one [EC no. 247-500-7]
and 2-methyl-4-isothia-
zolin-3-one [EC no. 220-239-6] (3:1)
55965-84-9Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H331
H311
H301
H314
H317
H400
H410
GHS06
GHS05
GHS09
Dgr
H331
H311
H301
H314
H317
H410
 Skin Corr. 1B;
H314: C ≥ 0,6 %
Skin Irrit. 2;
H315: 0,06 % ≤ C < 0,6 %
Eye Irrit. 2; H319:
0,06 % ≤ C < 0,6 %
Skin Sens. 1;
H317: C ≥ 0,0015 %
 
613-168-00-01-vinyl-2-pyrrolidone201-800-488-12-0Carc. 2
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Acute Tox. 4 (*)
STOT RE 2 (*)
STOT SE 3
Eye Dam. 1
H351
H332
H312
H302
H373 (*)(*)
H335
H318
GHS06
GHS05
GHS09
Dgr
H351
H332
H312
H302
H373 (*)(*)
H335
H318
  D
613-169-00-69-vinylcarbazole216-055-01484-13-5Muta. 2
Acute Tox. 4 *
Acute Tox. 4 *
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H341
H312
H302
H315
H317
H400
H410
GHS08
GHS07
GHS09
Wng
H341
H312
H302
H315
H317
H410
 M = 100 
613-170-00-12,2-ethylmethylthiazolidine404-500-3694-64-4Acute Tox. 4 (*)
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2
H302
H318
H317
H411
GHS05
GHS07
GHS09
Dgr
H302
H318
H317
H411
   
613-171-00-7hexaconazole (ISO);
(RS)-2-(2,4-dichlorophenyl)-1-
(1H-1,2,4-triazol-1-yl)hexan-2-ol
413-050-779983-71-4Acute Tox. 4 (*)
Skin Sens. 1
Aquatic Chronic 2
H302
H317
H411
GHS07
GHS09
Wng
H302
H317
H411
   
613-172-00-25-chloro-1,3-dihydro-2H-
indol-2-one
412-200-917630-75-0Repr. 2
Acute Tox. 4 (*)
Skin Sens. 1
Aquatic Chronic 3
H361f
(*)(*)(*)
H302
H317
H412
GHS08
GHS07
Wng
H361f
(*)(*)(*)
H302
H317
H412
   
613-173-00-8fluquinconazole (ISO);
3-(2,4-dichlorophenyl)-6-
fluoro-2-(1H-1,2,4-triazol-
1-yl)quinazolin-4-(3H)-one
411-960-9136426-54-5Acute Tox. 3 (*)
Acute Tox. 3 (*)
STOT RE 1
Acute Tox. 4 (*)
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H331
H301
H372 (*)(*)
H312
H315
H400
H410
GHS06
GHS08
GHS09
Dgr
H331
H301
H372 (*)(*)
H312
H315
H410
   
613-174-00-3tetraconazole (ISO);
(±) 2-(2,4-dichlorophenyl)-3-
(1H-1,2,4-triazol-1-yl)propyl-
1,1,2,2-tetrafluoroethylether
407-760-6112281-77-3Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Chronic 2
H332
H302
H411
GHS07
GHS09
Wng
H332
H302
H411
   
613-175-00-9epoxiconazole (ISO);
(2RS,3SR)-3-(2-chlorophenyl)-
2-(4-fluorophenyl)-[(1H-1,2,4-
triazol-1-yl)methyl]oxirane
406-850-2133855-98-8Carc. 2
Repr. 1B
Aquatic Chronic 2
H351
H360Df
H411
GHS08
GHS09
Dgr
H351
H360Df
H411
   
613-176-00-42-methyl-2-azabicyc-
lo[2.2.1]heptane
404-810-94524-95-2Flam. Liq. 3
Acute Tox. 4 (*)
Acute Tox. 4 (*)
STOT RE 2 (*)
Skin Corr. 1B
H226
H312
H302
H373 (*)(*)
H314
GHS02
GHS08
GHS05
GHS07
Dgr
H226
H312
H302
H373 (*)(*)
H314
   
613-177-00-X8-amino-7-methylquinoline412-760-45470-82-6Acute Tox. 4 (*)
Acute Tox. 4 (*)
Skin Sens. 1
Aquatic Chronic 2
H312
H302
H317
H411
GHS07
GHS09
Wng
H312
H302
H317
H411
   
613-178-00-54-ethyl-2-methyl-2-iso-
pentyl-1,3-oxazolidine
410-470-2137796-06-6Skin Corr. 1B
Skin Sens. 1
H314
H317
GHS05
GHS07
Dgr
H314
H317
 STOT SE 3;
H335: C ≥ 5 %
 
613-179-00-0lithium 3-oxo-1,2(2H)-
benzisothiazol-2-ide
411-690-1111337-53-2Acute Tox. 4 (*)
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 2
H302
H314
H317
H411
GHS05
GHS07
Dgr
H302
H314
H317
H411
   
613-180-00-6N-(1,1-dimethylethyl)bis(2-
benzothiazolesulfen)amide
407-430-13741-80-8Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410   
613-181-00-15,5-dimethyl-perhydro-
pyrimidin-2-one α-
(4-trifluoromethylstyryl)-
α-(4-trifluorome-
thyl)cinnamylidenehydrazone
405-090-967485-29-4STOT RE 1
Acute Tox. 4 (*)
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H372(*)(*)
H302
H319
H400
H410
GHS08
GHS07
GHS09
Dgr
H372 (*)(*)
H302
H319
H410